Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-5207

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-5207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

The text represents a graph showing the cumulative incidence rate (%), where "Atorastatn" and "Placsbo" are two measuring units. The graph shows that Atorastatn has a lower incidence rate compared to Placsbo, and an HR value of 0.64 with a p-value of 0.0005. The data is measured over the time frame of 20 to 35 years.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

The text presents a graph with cumulative hazard percentages for Placebo and Atorvastatin, with a horizontal axis of time in years and a vertical axis of hazard percentages. The graph shows that Atorvastatin achieved a lower hazard percentage than Placebo, with a HR of 0.63 and a p-value of 0.001 over four years of follow-up.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

This text provides a summary of the percentage of subjects experiencing events, specifically related to Atorvastatin dosages of 10 mg and 80 mg. The study also reports on the Hazard Ratio for Atorvastatin 80 mg compared to placebo. A graph shows the Time to First Major Cardiovascular Endpoint in years.*

FDA Label Image

Atorvastatin-st (Atorvastatin St)

FDA Label Image

Label Image (Lbl500905207)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.